Haw Par Corporation Ltd
SGX:H02
Haw Par Corporation Ltd
SGX:H02
Price:
9.64 SGD
-2.13%
Market Closed
Updated:
May 4, 2024
Haw Par Corporation Ltd
Operating Income
|
Haw Par Corporation Ltd
Operating Income Peer Comparison
Comparables:
WVE
H
1J5
I
42C
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Operating Income
S$65.3m
|
CAGR 3-Years
53%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Operating Income
-$68m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Operating Income
S$12.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Operating Income
-S$6.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Haw Par Corporation Ltd's Operating Income?
Operating Income
65.3m
SGD
65.3m
SGD
Based on the financial report for Dec 31, 2023, Haw Par Corporation Ltd's Operating Income amounts to 65.3m SGD.
What is Haw Par Corporation Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
5%
5%
Over the last year, the Operating Income growth was 46%. The average annual Operating Income growth rates for Haw Par Corporation Ltd have been 53% over the past three years , -5% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
